Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Blessie Nelson"'
Autor:
Ranjana Nawgiri, Avi B. Markowitz, Blessie Nelson, Ike Okereke, Maurice Willis, Angelina Hong, Palawinnage V. Muthukumarana
Publikováno v:
Diagnostic Cytopathology. 49:1150-1154
Nivolumab is commonly used as monotherapy or in combination therapy for management of locally advanced or metastatic melanoma; however, it is also associated with immunotherapy-related adverse events concerning for disease progression or tumor flare
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 1066-1070 (2021)
Case Reports in Oncology
Case Reports in Oncology
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome involving uncontrolled inflammation due to widespread activation of immune response. HLH can be inherited or acquired secondary to infection, autoimmune, or oncologic processes such as small lymp
Publikováno v:
Clinical Case Reports, Vol 8, Iss 12, Pp 2625-2628 (2020)
Clinical Case Reports
Clinical Case Reports
Causative factors of HUS due to infection are not limited to classic EHEC and Shigella infection. Understanding the effects of EPEC‐related HUS and its complications is imperative for early diagnosis and treatment to mitigate long‐term sequelae.
Publikováno v:
Journal of Hematology
Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented with EON, only 6 da
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Urothelial carcinoma therapy is a rapidly evolving and expanding field. Traditional cytotoxic chemotherapy regimens have not produced optimal long-term outcomes, and many urothelial cancer patients have comorbidities that disqualify them as chemother
Publikováno v:
Cureus
Diffuse large B-cell lymphoma (DLBCL) is one of several subtypes of non-Hodgkin’s lymphoma, and one that can present in a myriad of ways. One unique and particularly aggressive presentation is leukemic transformation with CD5 positivity, which lead
Publikováno v:
Journal of Surgical Case Reports
Growing teratoma syndrome (GTS) is documented in literature to be a rare complication of non-seminomatous germ cell tumors that arises following chemotherapeutic treatment. Though represented through multiple case reports, the condition is rare that
Publikováno v:
Journal of cancer policy. 28
Background Public interest in breast cancer is associated with breast cancer awareness month. However, no study has analyzed the temporal trends in breast cancer interest or assessed how funding for breast cancer research is influenced by public inte
Publikováno v:
Current problems in cancer. 46(1)
Introduction The Coronavirus Disease 2019 (COVID-19) pandemic has impacted breast, colon, prostate, and lung cancer screenings in the U.S. by decreasing screening numbers.We believe multiple types of cancer screenings may have been impacted during
Publikováno v:
Cureus
Plasmablastic lymphoma (PBL) is a rare form of non-Hodgkin lymphoma that is highly aggressive and carries a poor prognosis. Although the standard chemotherapy choice for most diffuse large B-cell lymphomas (DLBCL) is R-CHOP (rituximab, cyclophosphami